• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

Forty-Fourth ACBTSA Meeting: December 4-5, 2013

December 4, 2013 - December 5, 2013

NIH Conference Room 
5635 Fisher’s Lane, Terrace Level 
Rockville, MD 20852 

(U.S.)

Agenda

Wednesday, December 4, 2013

Time Agenda Item Presenter
07:30
(30 min)
Doors Open Open to the Public
08:00
(10 min)
Call to Order Jay Menitove, MD
Committee Chair
08:10
(5 min)
Roll Call James Berger
Executive Secretary

Committee Business

Time Agenda Item Presenter
08:15
(30 min)
Assistant Secretary for Health’s Charge to the Committee   Howard K. Koh, MD, MPH
HHS Assistant Secretary for Health  

Advisory Committee Updates-I

Time Agenda Item Presenter
08:45
(30 min)
Disease Transmission Advisory Committee
  • Progress in implementing new PHS Guideline for Reducing Transmission of HIV, HBV, and HCV through Organ Transplantation
Michael Green, MD, MPH
Chair, OPTN/UNOS ad hoc Disease Transmission Advisory Committee Professor of Pediatrics, Surgery & Clinical and Translational Science University of Pittsburgh School of Medicine Division of Infectious Diseases Children’s Hospital of Pittsburgh 

Reports on WHO Products of Human Origin (MPHO) Initiativeand an HHS Innovation Project

Time Agenda Item Presenter
09:15
(40 min)
WHO initiative on fostering  consensus on global requirements for Medical Products of Human Origin (MPHO) Luc Noel, MD, Msc
Patient Safety Special Adviser Initiative for MPHO World Health Organization
09:55
(40 min)
HHS Innovation Project on Organ Electronic Tracking and Transport   Chris McLaughlin
Chief, Organ Transplantation Branch Division of Transplantation HRSA

David Cartier
HHS Entrepreneur Division of Transplantation HRSA

Advisory Committee Updates-II

Time Agenda Item Presenter
10:35
(10 min)
Blood Products Advisory Committee (BPAC) Update
  • November meeting on interpretive criteria for MP Diagnostics HTLV Blot 2.4
Pradip Akolkar, PhD
FDA/CBER/OBRR  
10:45
(10 min)
Advisory Committee on Organ Transplantation (ACOT) Update
  • New definition of human organ
Mark Barr, MD
Chair, Advisory Committee on Organ Transplantation, HHS / HRSA
10:55 Break • 10 min  

ACBTSA Subcommittee Reports

Time Agenda Item Presenter
11:05
(40 min)
Subcommittee Update: Tissue Safety and Availability in Emergencies   Tim Pruett, MD
Chief, Division of Transplantation University of Minnesota  
11:45
(40 min)
Subcommittee Update: Blood Safety and Availability in Emergencies Aryeh Shander, MD Chief, Department of Anesthesiology, Critical Care Medicine, Hyperbaric Medicine & Pain Management Englewood Hospital & Medical Center   Clinical Professor of Anesthesiology, Medicine & Surgery Mount Sinai School of Medicine
12:25
(5 min)
Subcommittee Update: Informed Consent in Transfusions and Transplantation   Debbie Seem, RN, MPH
Advisor for Tissue Safety and Availability HHS/OASH/OHAIDP  
12:30 Lunch Break • 45 min  
01:15
(30 min)  
Open Public Hearing (all sessions/considerations)  
01:45
(1.5 hrs)
Committee Questions, Discussion, and Recommendations  
03:15 Adjournment Jay Menitove, MD
Committee Chair  

Thursday, December 5, 2013

Time Agenda Item Presenter
07:30
(30 min)
Doors Open Open to the Public
08:00
(5 min)
Call to Order Jay Menitove, MD
Committee Chair  
08:05
(10 min)
Roll Call   James Berger
Executive Secretary  

Optimal Blood Service Delivery in the Current Era of Health Care Reform

Time Agenda Item Presenter
08:15
(40 min)
Cost Recovery System of Blood Centers Miriam Markowitz
Chief Executive Officer AABB  
08:55
(40 min)
Capacity for Product and Service Innovation within the Blood Industry   Raymond Goodrich, PhD
Vice President Scientific and Clinical Affairs; Chief Science Officer Blood Bank Technologies Terumo BCT  
09:35
(40 min)
Promotion of Risk-Based Decision Making from Donor to Recipient   Judie Leach Bennett
Director Centre for Innovation Canadian Blood Services  
10:15 Break • 10 min  

Update on Blood Donor Policy for Men who have Sex with Men

Time Agenda Item Presenter
10:25
(15 min)
Review of ACBSA’s 2010 Decision and Progress Since James Berger
Executive Secretary  
10:40
(40 min)
Results from the Uniform Donor History Questionnaire Kristen Miller, PhD, BCBA-D
CDC/OSELS/NCHS

Stephanie Willson, PhD
CDC/OSELS/NCHS  
11:20
(20 min)
Review of the Goals and Work Product of the Quarantine Release Error Task Force   M. Allene Carr-Greer, MT(ASCP) SBB
Director Regulatory Affairs AABB  
11:40
(5 min)
Update on the Recipient Epidemiology and Donor Evaluation Study – III (REDS-III) Blood Donation Rules Opinion Study (Blood DROPS)   Brian Custer, PhD, MPH
Associate Investigator Epidemiology and Health Research Policy Blood Systems Research Institute
11:45
(15 min)  
Open Public Hearing (all sessions/considerations)  
12:00 Lunch Break • 45 min  
12:45
(20 min)
REDS-II: Feasibility of Constructing a Multicenter Blood Donation Database for Surveillance Purposes in the United States Edward Notari, MPH
Project Manager III American Red Cross
01:05
(20 min)
REDS-II: Risk Factor Analysis for a Blood Surveillance Program Brian Custer, PhD, MPH
Associate Investigator Epidemiology and Health Research Policy Blood Systems Research Institute  
01:25
(30 min)
Establishing a U.S. Donor Transfusion-Transmissible Infection Monitoring System—Next Steps Simone Glynn, MD, MPH
Branch Chief Transfusion Medicine and Cellular Therapeutics National Heart, Blood, and Lung Institute  
01:55
(1.5 hrs)
Committee Questions, Discussion, and Recommendations  
03:30 Adjournment Jay Menitove, MD
Committee Chair  
Back to Top